Evidence map›Paper›PMID 21826554›Full record

ArticleMolecular biotechnology2012

Developing an extended genomic engineering approach based on recombineering to knock-in heterologous genes to Escherichia coli genome.

Karan Sukhija, Michael Pyne, Saad Ali, Valerie Orr, Daryoush Abedi, Murray Moo-Young, C Perry Chou

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Identification of a Depolymerase Specific for K64-SerotypeAntibiotics (Basel, Switzerland) · 2021
    Article
  3. Article
  4. Development of a SensitiveFrontiers in microbiology · 2019
    Article
  5. A Multiplex Genome Editing Method forFrontiers in microbiology · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Engineering Escherichia coli for high-level production of propionate.Journal of industrial microbiology & biotechnology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Karan SukhijaDepartment of Chemical Engineering, University of Waterloo, Waterloo, ON N2L 3G1, Canada.
Michael Pyne
Saad Ali
Valerie Orr
Daryoush Abedi
Murray Moo-Young
C Perry Chou
University of Waterloo · CAIsfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most existing genomic engineering protocols for manipulation of Escherichia coli are primarily focused on chromosomal gene knockout. In this study, a simple but systematic chromosomal gene knock-in method was proposed based on a previously developed protocol using bacteriophage λ (λ Red) and flippase-flippase recognition targets (FLP-FRT) recombinations. For demonstration purposes, DNA operons containing heterologous genes (i.e., pac encoding E. coli penicillin acylase and palB2 encoding Pseudozyma antarctica lipase B mutant) engineered with regulatory elements, such as strong/inducible promoters (i.e., P( trc ) and P( araB )), operators, and ribosomal binding sites, were integrated into the E. coli genome at designated locations (i.e., lacZYA, dbpA, and lacI-mhpR loci) either as a gene replacement or gene insertion using various antibiotic selection markers (i.e., kanamycin and chloramphenicol) under various genetic backgrounds (i.e., HB101 and DH5α). The expression of the inserted foreign genes was subjected to regulation using appropriate inducers [isopropyl β-D: -1-thiogalactopyranoside (IPTG) and arabinose] at tunable concentrations. The developed approach not only enables more extensive genomic engineering of E. coli, but also paves an effective way to "tailor" plasmid-free E. coli strains with desired genotypes suitable for various biotechnological applications, such as biomanufacturing and metabolic engineering.

Indexed as

Genome, BacterialEscherichia coliEscherichia coli ProteinsFungal ProteinsGene Expression Regulation, BacterialGene Knock-In TechniquesGenetic EngineeringLipaseModels, GeneticPenicillin AmidaseRecombinant ProteinsRegulatory Sequences, Nucleic AcidEscherichia coli ProteinsFungal ProteinsLipasePenicillin AmidaseRecombinant Proteins

Identifiers

PMID21826554
OpenAlexW2061838053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.